- Home
- BUR vs RNA Comparison
BUR vs RNA Comparison
Compare BUR & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUR
- RNA
- Stock Information
- Founded
- BUR 2009
- RNA 2012
- Country
- BUR Guernsey
- RNA United States
- Employees
- BUR N/A
- RNA N/A
- Industry
- BUR Finance: Consumer Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- BUR Finance
- RNA Health Care
- Exchange
- BUR Nasdaq
- RNA Nasdaq
- Market Cap
- BUR 3.3B
- RNA 3.7B
- IPO Year
- BUR 2010
- RNA 2020
- Fundamental
- Price
- BUR $15.33
- RNA $31.12
- Analyst Decision
- BUR Strong Buy
- RNA Strong Buy
- Analyst Count
- BUR 2
- RNA 10
- Target Price
- BUR $18.00
- RNA $65.80
- AVG Volume (30 Days)
- BUR 735.1K
- RNA 1.3M
- Earning Date
- BUR 03-13-2025
- RNA 03-07-2025
- Dividend Yield
- BUR 0.82%
- RNA N/A
- EPS Growth
- BUR N/A
- RNA N/A
- EPS
- BUR 1.16
- RNA N/A
- Revenue
- BUR $1,284,243,000.00
- RNA $10,117,000.00
- Revenue This Year
- BUR N/A
- RNA N/A
- Revenue Next Year
- BUR $23.71
- RNA N/A
- P/E Ratio
- BUR $13.20
- RNA N/A
- Revenue Growth
- BUR 1129.87
- RNA N/A
- 52 Week Low
- BUR $12.07
- RNA $13.73
- 52 Week High
- BUR $16.77
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- BUR 67.82
- RNA 44.06
- Support Level
- BUR $14.94
- RNA $31.14
- Resistance Level
- BUR $15.53
- RNA $33.37
- Average True Range (ATR)
- BUR 0.30
- RNA 1.67
- MACD
- BUR 0.05
- RNA -0.16
- Stochastic Oscillator
- BUR 84.62
- RNA 11.27
About BUR Burford Capital Limited
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Capital provision, which is the provision of capital to the legal industry or in connection with legal matters, both directly and through investment in the group's managed funds; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.